ERCC1 expression levels determined the sensitivity of cells to Pt in part [34], and LRP expression was associated with resistance to anti-cancer drugs including cisplatin, carboplatin, doxorubicin, etoposide and paclitaxel in vitro [35]. The gene discussed is ERCC1; the disease is cancer.